Search results
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 1 day agoLouis...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 3 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
Melanoma skin cancer vaccine being trialled on NHS halves risk of death or relapse
Daily Telegraph· 2 days agoMeanwhile, another study by the Danish biotech firm Evaxion and the Melanoma Institute Australia at...
Cancer vaccine hailed as 'game-changer'
Newsweek· 6 days agoCancer patients in the U.K. are about to get personalized cancervaccines as part of a new trial. Unlike vaccines for diseases like the flu or COVID-19,...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 2 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 2 days agoEfforts are already underway for 200 patients in the US and Europe to receive personalized cancer ...
Thousands of NHS patients to trial new personalised cancer vaccine in ‘landmark moment’
The Independent via Yahoo News· 6 days agoThousands of NHS patients will be given access to groundbreaking cancer vaccines, health leaders...
Thousands of cancer patients to trial personalised vaccines
BBC via Yahoo News· 6 days agoElliot Pfebve is taking part in the trial [BBC] Thousands of NHS cancer patients in England are...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 3 days agoModerna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented the latest...
NHS launches personalised mRNA cancer vaccines trial
Clinical Trials Arena via Yahoo Finance· 6 days agoThe NHS has commenced a clinical trial offering personalised cancer vaccines being developed by BioNTech and Genentech to patients. The first patient was...